This inventor holds 1 USPTO granted patent. Top assignee: Promd Biotech Co., Ltd.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Hsiang Ling Chen: Innovator in PPARγ Expression Enhancement
Introduction
Hsiang Ling Chen is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of biotechnology, particularly in enhancing PPARγ expression. His innovative approach has the potential to impact various health-related applications.
Latest Patents
Hsiang Ling Chen holds a patent for a method aimed at enhancing PPARγ expression. The patent, titled "Method for enhancing PPARγ expression," involves administering an effective amount of PM-A0005 to a subject in need. This compound has been deposited under the Budapest Treaty in the China Center for Type Culture Collection (CCTCC), China, with Deposition No. M 207039. This patent highlights his commitment to advancing medical science through innovative methodologies.
Career Highlights
Chen is associated with Promd Biotech Co., Ltd., where he continues to develop and refine his inventions. His work at this company underscores his dedication to translating scientific research into practical applications that can benefit society.
Collaborations
Some of his notable coworkers include Wei-Chih Su and Chun-Hsien Huang. Their collaborative efforts contribute to the innovative environment at Promd Biotech Co., Ltd.
Conclusion
Hsiang Ling Chen's work in enhancing PPARγ expression exemplifies the impact of innovative thinking in biotechnology. His contributions are paving the way for advancements in health and medicine.